share_log

富士莱(301258.SZ)：公司生物酶催化法生产的R-硫辛酸已经实现量产

Fujilai (301258.SZ): The company has achieved mass production of R-Octanoic acid produced by biocatalytic method.

Gelonghui Finance ·  Jun 21 03:51

On June 21, Gelunhui reported that Fujilai (301258.SZ) announced on the investor interaction platform that its biocatalytic production of R-thioctic acid has been put into mass production. It is mainly used for external sales and preparation of R-thioctic acid sodium salt. Currently, it is still in the market promotion stage, and whether it can completely replace the original process depends on market demand, customer acceptance, and other factors. In 2023, the revenue from this type of business will account for no more than 3% of the company's total revenue, with a relatively small proportion, and there are no clear expansion plans yet.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment